CAS: 104987-12-4; (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26As)-8-Ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26A-Hexadecahydro-5,19-Dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-Hydroxy-3-Methoxycyclohexyl]-1-Methylethenyl]-14,16-Dimethoxy-4,10,12,18-Tetramethyl-15,19-Epoxy-3H-Py

该化合物是一种大型滑坡抗生素,其产物是某些真菌物种发酵,特别是基因*Aspergillus* 中的真菌,它展示了广泛的抗反芬基活动,主要针对各种真菌菌菌株,包括*Candida* 和*Aspergilus* .通过阻止真菌细胞壁合成,从而阻止生长和复制,因此防止了生长和复制.除了防烟剂的特性外,它还显示出免疫抑制效应,使它在器官移植和自动免疫性疾病方面引起兴趣.该化合物的特点是复杂的宏观结构,包括大型乳腺环和多种功能组,有助于其生物活动.阿斯科辛因其威力和潜在副作用,通常在严格的医学监督下在临床环境中管理.其溶液性和稳定性因配方而不同,影响其药剂,药理学和治疗功效.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

24,33-bis-OTBDMS-ascomycin 11-epi-ascomycin 2(R),10(S),11(S)-cyclo-ascomycin 61H113NO12Si3C61H113NO12Si343H69NO12C43H69NO12 L 685818 33-(tert-butyldimethylsilyl)-24-deoxy-ascomycin 52H77NO14C52H77NO14

合成工艺路线路线简述

    11-Epi-Ascomycin置于三乙胺体系中,用 乙腈 用作溶剂,化学反应生成长川霉素
    参考文献:Selective Transformation Of Ascomycin Into 11-Epi-Ascomycin
    标题:Selective Transformation Of Ascomycin Into 11-Epi-Ascomycin
    摘要:Within The Binding Domain,Ascomycin Features The Unusual Pattern Of A Masked Tricarbonyl Moiety,Which Potentially Allows For High Structural Diversity Via Simple Isomerisation Events. A Cascade Of Diastereoselective Rearrangement Reactions At The Binding Domain,Allowing The Conversion Of Ascomycin Into 11-Epi-Ascomycin Is Herein Reported. (C) 2003 Elsevier Ltd. All Rights Reserved.
    Doi:10.1016/j.Tetlet.2003.10.199

    专利信息


    专利号:US-2004018598-A1
    优先权日:2000-05-30
    标题 :Bio-intermediates for use in the chemical synthesis of polyketides
    发明人:SANTI DANIEL; ASHLEY GARY; MYLES DAVID C
    摘要:The present invention relates to compounds made by a subset of modules from one or more polyketide synthase (“PKSâ€?) genes that are used as starting material in the chemical synthesis of novel molecules, particularly naturally occurring polyketides or derivatives thereof. The biologically derived intermediates (“bio-intermediatesâ€?) generally represent particularly difficult compounds to synthesize using traditional chemical approaches due to one or more stereocenters. In one aspect of the invention, an intermediate in the synthesis of epothilone is provided that feeds into the synthetic protocol of Danishefsky and co-workers. In another aspect of the invention, intermediates in the synthesis of discodermolide are provided that feed into the synthetic protocol of Smith and co-workers. By taking advantage of the inherent stereochemical specificity of biological processes, the syntheses of key intermediates and thus the overall syntheses of compounds like epothilone and discodermolide are greaty simplified.

    专利号:US-9315483-B2
    优先权日:2007-09-13
    标题 :Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof
    发明人:JONES ANDREW D; ZELLE ROBERT E; SILVERMAN I ROBERT
    权利人:CONCERT PHARMACEUTICALS INC
    摘要:The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.

    专利号:US-5446158-A
    优先权日:1989-01-11
    标题:Process for synthesis of FK-506 and tricarbonyl intermediates
    发明人:JONES TODD K; MILLS SANDER G; ASKIN DAVID; REAMER ROBERT A; DESMOND RICHARD; TSCHAEN DAVID M; VOLANTE RALPH P; SHINKAI ICHIRO
    权利人:MERCK & CO INC
    摘要:A process is described for the total synthesis of the macrolide immunosuppressant, FK-506, and important tricarbonyl process intermediates thereof. The tricarbonyl intermediates can be produced by the mild oxidation of 2,3-dihydroxy carboxylate compounds containing olefin moieties.

    专利号:US-8778636-B2
    优先权日:2009-05-22
    标题:Chemo-enzymatic approach to the synthesis of pimecrolimus
    发明人:GRISENTI PARIDE; REZA ELAHI SHAHRZAD; VERZA ELISA
    权利人:GRISENTI PARIDE; REZA ELAHI SHAHRZAD; VERZA ELISA; EUTICALS SPA
    摘要:Processes for preparing pimecrolimus starting from ascomycin, exploiting the selectivity characteristics of the purified enzymatic systems particularly regarding the selective functionalization of the hydroxyl groups present in position 24 and 33 of ascomycin. Such method represents the first example of chemoenzymatic synthesis for preparing pimecrolimus.

    专利号:US-6004787-A
    优先权日:1991-01-17
    标题:Method of directing biosynthesis of specific polyketides
    发明人:KATZ LEONARD; DONADIO STEFANO; MCALPINE JAMES B
    权利人:ABBOTT LAB
    摘要:A method to produce novel polyketide structures by designing and introducing specified changes in the DNA governing the synthesis of the polyketide is disclosed. The biosynthesis of specific polyketide analogs is accomplished by genetic manipulation of a polyketide-producing microorganism by isolating a polyketide biosynthetic gene-containing DNA sequence, identifying enzymatic activities associated within the DNA sequence, introducing one or more specified changes into the DNA sequence which codes for one of the enzymatic activities which results in an altered DNA sequence, introducing the altered DNA sequence into the polyketide-producing microorganism to replace the original sequence, growing a culture of the altered microorganism under conditions suitable for the formation of the specific polyketide analog, and isolating the specific polyketide analog from the culture. The method is most useful when the segment of the chromosome modified is involved in an enzymatic activity associated with polyketide biosynthesis, particularly for manipulating polyketide synthase genes from Saccarharopolyspora or Streptomyces.

    专利号:WO-9313663-A1
    优先权日:1992-01-17
    标 题:Method of directing biosynthesis of specific polyketides
    发明人:KATZ LEONARD; DONADIO STEFANO; MCALPINE JAMES B
    权利人:ABBOTT LAB
    摘要:A method to produce novel polyketide structures by designing and introducing specified changes in the DNA governing the synthesis of the polyketide is disclosed. The biosynthesis of specific polyketide analogs is accomplished by genetic manipulation of a polyketide-producing microorganism by isolating a polyketide biosynthetic gene-containing DNA sequence, identifying enzymatic activities associated within the DNA sequence, introducing one or more specified changes into the DNA sequence which codes for one of the enzymatic activities which results in an altered DNA sequence, introducing the altered DNA sequence into the polyketide-producing microorganism to replace the original sequence, growing a culture of the altered microorganism under conditions suitable for the formation of the specific polyketide analog, and isolating the specific polyketide analog from the culture. The method is most useful when the segment of the chromosome modified is involved in an enzymatic activity associated with polyketide biosynthesis, particularly for manipulating polyketide synthase genes from Saccharapolyspora or Streptomyces.
    台州市科瑞生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.pharm-intermediates.com
    企业联系电话:0576-88813233👤
    📞台州市科瑞生物技术有限公司 ⚠️参考联系方式
    联系人:金崇光
    电话:0576-88813233
    手机:13396860566
    传真:0576-88813233
    邮箱:sales@pharm-intermediates.com
    通信地址: 台州市开发大道东段288号
    邮编: 318000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:台州市开发大道东段288号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    北京海步国际医药科技发展有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hopelife.cn
    电话: 86-10-67886402👤
    📞北京海步国际医药科技发展有限公司 ⚠️参考联系方式

    销售电话:86-10-67886402
    邮箱:apis@hopelife.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海泽涵生物医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.zehanbiopharma.com
    电话: 021-61350663 13052117465👤
    📞上海泽涵生物医药科技有限公司 ⚠️参考联系方式

    销售电话:021-61350663 13052117465
    邮箱:sales@zehanbiopharma.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北威德利化学科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.widelychemical.com
    企业联系电话:13385289472👤
    📞湖北威德利化学科技有限公司 ⚠️参考联系方式
    联系人:赵方
    电话:13385289472
    手机:13385289472
    传真:027- 59222918
    邮箱:z13385289472@163.com
    通信地址: 湖北省武汉市硚口区解放大道204号
    邮编: 430033
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省武汉市硚口区解放大道204号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Qi H, Zhao S, Fu H, Wen J, Jia X. Enhancement of ascomycin production in Streptomyces hygroscopicus var. ascomyceticus by combining resin HP20 addition and metabolic profiling analysis. J Ind Microbiol Biotechnol. 2014 Sep;41(9):1365-74. doi: 10.1007/s10295-014-1473-9. Epub 2014 Jun 26. doi: 10.1007/978-3-7091-0748-5_2. Review. doi: 10.1111/j.1527-3458.2008.00036.x. Review. Epub 2006 Jul 26. Epub 2005 Mar 4. Epub 2002 Jan 10. Review.

    合成参考文献


    参考文献:10.1038/emm.1999.12
    摘要:Rhew J, Shin Y, Lee B, Park R, Kim I. Induction of fibronectin gene expression by inhibitors of protein phosphatase type 2B in normal and transformed fibroblasts. Experimental & Molecular Medicine. 1999 Jun 01;31(2):71–5. doi: 10.1038/emm.1999.12.
    参考文献:10.1007/s002800050960
    摘要:Mealey KL, Barhoumi R, Burghardt RC, McIntyre BS, Sylvester PW, Hosick HL, Kochevar DT. Immunosuppressant inhibition of P-glycoprotein function is independent of drug-induced suppression of peptide-prolyl isomerase and calcineurin activity. Cancer Chemotherapy and Pharmacology. 1999 Jun 17;44(2):152–8. doi: 10.1007/s002800050960.
    参考文献:10.2165/00128071-200203030-00003
    摘要:Cather J, Menter A. Novel Therapies for Psoriasis. American Journal of Clinical Dermatology. 2002 Apr;3(3):159–73. doi: 10.2165/00128071-200203030-00003.
    参考文献:10.1007/s11302-007-9052-4
    摘要:Bartholomew J, Reichart J, Mundy R, Recktenwald J, Keyser S, Riddle M, Kuruvilla H. GTP avoidance in Tetrahymena thermophila requires tyrosine kinase activity, intracellular calcium, NOS, and guanylyl cyclase. Purinergic Signalling. 2007 Feb 24;4(2):171–81. doi: 10.1007/s11302-007-9052-4.
    参考文献:10.1007/128_2011_151
    摘要:Schiene-Fischer C, Aumüller T, Fischer G. Peptide bond cis/trans isomerases: a biocatalysis perspective of conformational dynamics in proteins. Top Curr Chem. 2013;328():35–67. doi: 10.1007/128_2011_151.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知